Zimmer Biomet Gains Japan Approval for Innovative Iodine-Enhanced Hip Implants
- Zimmer Biomet received approval for iTaperloc® Complete and iG7™ Hip System from Japan's PMDA, advancing orthopedic implants.
- The new hip systems utilize Iodine Technology to combat Periprosthetic Joint Infection, enhancing infection management in surgeries.
- This approval enhances Zimmer Biomet's portfolio and commitment to innovative solutions for surgical infection risks and patient safety.
Zimmer Biomet Secures Approval for Innovative Hip Implants in Japan
Zimmer Biomet Holdings, Inc., a prominent player in global medical technology, achieves a significant milestone by receiving approval from Japan's Pharmaceutical and Medical Devices Agency (PMDA) for its iTaperloc® Complete and iG7™ Hip System. This marks an important advancement in orthopedic implants, as these systems are the first to incorporate Iodine Technology, specifically designed to address the critical challenge of Periprosthetic Joint Infection (PJI). PJI, which affects 1-2% of total joint arthroplasties, poses serious health risks, with mortality rates that can reach up to 11% over five years, comparable to breast cancer and significantly higher than prostate cancer.
The iTaperloc and iG7 systems leverage the established clinical success of the Taperloc Complete Hip System alongside the innovative features of the G7 Acetabular System. A key component of these implants is a controlled-release iodine layer, which is biocompatible and resistant to antibiotic resistance. This layer is applied to the surface of the implants during manufacturing, effectively inhibiting bacterial adhesion and preventing biofilm formation, which are critical factors in the development of PJI post-surgery. The integration of this technology positions Zimmer Biomet at the forefront of infection management in orthopedic procedures.
Ivan Tornos, Chairman, President & CEO of Zimmer Biomet, underscores the significance of this approval, noting that it enhances the company's portfolio of infection management solutions. This portfolio not only includes advanced implants but also a range of products dedicated to infection prevention, detection, and revision. Tornos emphasizes the commitment of Zimmer Biomet to equip surgeons with the necessary tools to manage infection risks effectively, ultimately supporting safer surgical outcomes for patients. This product approval reflects the company’s ongoing dedication to delivering transformative innovations that address critical challenges in musculoskeletal health.
In addition to the iTaperloc and iG7 systems, Zimmer Biomet continues to innovate within the orthopedic space, contributing to enhanced surgical techniques and improved patient outcomes. The approval of these implants in Japan signifies a broader commitment to addressing global health challenges related to joint surgeries.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

